Enterprise Value
3.244B
Cash
239.6M
Avg Qtr Burn
-20.18M
Short % of Float
10.84%
Insider Ownership
0.75%
Institutional Own.
-
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Galafold (migalastat) Details Fabry disease | Approved Quarterly sales | |
Approved Quarterly sales | ||
AT-GTX-501 Details Batten Disease | Failed Discontinued | |
AT-GTX-502 Details Batten Disease | Failed Discontinued |